Xtx Topco LTD Syros Pharmaceuticals, Inc. Transaction History

Xtx Topco LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.69 - $1.21 $30,742 - $53,911	-44,555 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$1.02 - $3.8 $33,691 - $125,517	33,031 Added 286.63%	44,555 $53,000
Q4 2021 Feb 11, 2022	BUY	$3.26 - $4.66 $37,568 - $53,701	11,524 New	11,524 $38,000
Q3 2021 Nov 12, 2021	SELL	$4.08 - $5.66 $106,153 - $147,261	-26,018 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$5.01 - $7.48 $74,393 - $111,070	14,849 Added 132.95%	26,018 $142,000

Q1 2021 May 14, 2021	BUY	$7.19 - $14.95 $80,305 - $166,976	11,169 New	11,169 $84,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $104M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.